Introduction
At present, radiotherapy is an interdisciplinary field employing an advanced therapeutic and imaging apparatus and computerized therapy planning and simulation systems. This means that both the patient-related aspects (diagnosis, selection, treatment indication, justification, referral, planning, therapy, follow-up) and the control and measurement procedures, forming the technical part of the treatment process, should be subject to regular planning, verification and, most importantly, constant improvement [1] .
While as of late, quality assurance in radiotherapy has been believed to play a key role in ensuring safe and effective treatment in the physical and technical context (efficient equipment, in vivo dosimetry, portal imaging), now a more systemic approach to quality is beginning to prevail [2] [3] [4] . This, however, calls for designing, implementing, maintaining and improving formalized quality systems or, in other words, implementing versatile quality management systems to cover all areas of activity (administrative, organizational, physical, technical and clinical) of a health care institution applying ionizing radiation for medical purposes.
Aim of the study
The aim of this study is to present clinical quality standards for radiotherapy as developed by the author.
The clinical standards were divided into the following categories:
1. A detailed description of the clinical standards is provided in Table 1 .
Conclusion
The proposed clinical quality standards can be used in any institution employing ionizing radiation for medical purposes.
However, quality standards are of value only if implemented, regularly reviewed and improved through a quality management system functioning in the institution concerned to enable verification whether the pre-set standards are complied with.
Therefore, it is also very important that a quality management system is developed and implemented to contribute to: a) improvement of work organization, b) quality of service provided, c) reduction of activity costs owing to rational material management, d) patient-orientation, e) reduction in the number of non-conformities and failures, and costs of their removal, f) increased patient and staff safety through on-going control of equipment and work place; application of uniform procedures and documentation, g) creation of a clear organisational structure with regard to the responsibility for assigned work, h) strengthening of teamwork and cooperation between staff members and organisational units, i) increased commitment of the staff in continuous improvement of the institution and its QMS.
1. Patients hospitalised in the institution shall be subjected to medical exposure for diagnostic or therapeutic purposes, only when so prescribed by a medical practitioner. 2. Examination or treatment involving ionizing radiation require a written referral issued by a practitioner authorised to prescribe examination or treatment involving ionising radiation. 3. Examinations involving ionizing radiation without doctor's referral may only be made under screening projects. 4. Decision to apply radiotherapy shall be based on patient interview, assessment of patient's health and psychosocial status, physical and pathology examination results, cancer staging, and patient's medical documentation. 5. Results of diagnostic tests shall form an integral part of patient's medical documentation and remain available before, during and after treatment. 6. The institution shall evaluate patient's psychosocial condition and accordingly adjust its health care and treatment options. 7. Referral for radiotherapy shall be made in writing and duly authenticated (by signature, stamp and date) by a radiation oncologist. 8. Prescription for radiotherapy shall include planning target volume, gross tumour volume and clinical target volume (PTV, GTV, CTV) according to the rules provided by ICRU 50, ICRU 62, and ICRU 38 reports, total dose, method of fractioning, total duration of therapy, planned intervals, and description of treatment techniques pursuant to applicable therapeutic protocols. 9. Prescription for radiotherapy shall be forwarded to the team responsible for treatment planning (medical physicist, dosimetrist, radiologic technologist) who do necessary calculations and planning. 10. The institution shall hold treatment waiting lists. R Re ef fe er rr ra al l f fo or r t tr re ea at tm me en nt t/ /d de ec ci is si io on n t to o t tr re ea at t/ /t tr re ea at tm me en nt t p pr re es sc cr ri ip pt ti io on n T Th he er ra ap pe eu ut ti ic c ( (t tr re ea at tm me en nt t) ) p pr ro ot to oc co ol l 4 . Responsible physicians shall make sure that information provided to patients and their families is well understood. 5. Patients shall give their written and informed consent to each examination and treatment (application of contrast agent, MRI, radiotherapy). 6. Patients shall give their written and informed consent to radiotherapy, before it is begun and after getting acquainted with information provided by the physician (in oral, written, audiovisual or other form) on the stage of the disease, prognosis, course of treatment, possible severe and late complications and side effects, and alternative treatment options, as well as procedures to be used before, during and after treatment. 7. Before providing information to the patient, physicians shall take a due account of patient's psychosocial conditions. 8. Patients shall confirm their consent to treatment by a legible signature in a radiotherapy consent form. 9. The radiotherapy consent form shall be an integrated part of patient's medical documentation. 10. Patients shall be informed of their rights and duties in the institution (orally or in writing). 11. Patient's rights and duties within the institution are communicated at that institution and available to both patients and staff (e.g. information boards). 12. Patients shall be informed of any non-conformities during treatment (e.g. under-exposure, overexposure). 13. Patients shall be informed of their right to make complaints, grievances or comments about the work of the institution, services provided and treatment delivered. 14. Radiation therapists shall, upon completion of radiotherapy, inform the referring physicians of the course of treatment. 15. The institution has developed and put in place a procedure for information flow between the institution and its patients and feedback from patients, in particular with regard to complaints and grievances. 16. The institution shall hold regular meetings between the therapeutic and radiotherapy teams.
1. Treatment planning shall be performed in consultation with a radiation oncologist, medical physicist, and, if possible, a radiologic technologist. 2. The planning treatment process should, to the extent possible, take into account patient's expectations (e.g. preferred time of procedure). 3. Therapy involving ionizing radiation shall be preceded by the development of a treatment plan including data necessary for proper delivery of radiation and simulation of planned radiation beams. 4. The simulation shall be recorded as an X-ray image or in a digital form. 5. Each decision to give up simulation for medical reasons only, shall be recorded in patient's medical documentation. 6. The simulations shall be made in the presence of a radiation oncologist, radiologic technologist and, if necessary, medical physicist. 7. 3D treatment planning shall include: a) a series of CT images at intervals of no more than 10 mm, b) 3D representation of the target volume and critical organs, c) treatment plan documentation in the form of Dose Volume Histograms (DVHs) in the target volume and critical organs.
I In nt te er rd di is sc ci ip pl li in na ar ry y a ap pp pr ro oa ac ch h C Co om mm mu un ni ic ca at ti io on n T Tr re ea at tm me en nt t p pl la an nn ni in ng g 8. The institution has set rules for maximum and minimum dose in PTV and margins between CTV and PTV. 9. Treatment plans shall be validated by a radiation oncologist and planning medical physicist. 10. Treatment plan shall include instructions for patient immobilisation (if applicable). 11. Treatment plan shall include information on radiation field, as well as accessories and compensators to be used. 12. Radiation oncologist shall be responsible for marking the radiation field on patient's body and keeping the markings legible throughout the therapy. 13. All treatment plans and difficult cases shall be consulted at regular (weekly) consultation meetings. 14. The institution has defined the scope and frequency of consultation meetings. Consultation meetings shall be minuted and the minutes archived.
1. Electronic transfer of data (treatment parameters) from the SPL to a therapy machine shall be double checked. 2. The institution has defined the frequency and person responsible for controlling data transfer.
Each control shall be documented and authenticated. 3. Treatment plan shall be checked no later than before the second radiation fraction. 4. Controls of radiation duration and dose shall be performed no later than before the second therapy session, except for treatments planned to take less than six days. In that case, controls shall be performed before radiation is started. 5. The institution has implemented and documented the procedure for assessment of errors and non-conformities found during the verification of treatment plans and during the radiation process, including sources of such errors/non-conformities, time (stage) of detection and their impact on radiation dose: a) the institution has defined error/non-conformity source categories, e.g. documentation, dose calibration, treatment plan, patient position/immobilisation (EPID), medical documentation/ patient data management system, equipment breakdown, accidental error; b) the institution has established stages for possible error/non-conformity detection, e.g. stage 1 -before treatment (fraction), stage 2 -during radiation, stage 3 -after radiation; c) the institution shall analyse the impact of identified errors/non-conformities on potential and actual deviation of dose distribution. 6. The institution has implemented and documented a procedure for double independent check of calculated time of irradiation or number of monitor units per radiation field. 7. Controls shall be confirmed with controller's signature and date. 8. Any changes in treatment plans shall be validated by a radiation oncologist and, where procedurally required, medical physicist. 9. The following shall be checked before a treatment onset: a) correctness and durability of tattoos, b) correctness of recorded treatment physical parameters, c) reproducibility of patient's positioning, d) method of patient's immobilisation (to ensure reproducibility), e) functional and mechanical stability, f) unambiguous patient identification, including documentation and individual accessories used in the process of treatment (masks, shields).
1. All treatment procedures and related diagnosis shall be performed or supervised by radiation oncologists (if performed by doctors being trained in this speciality or radiologic technologists). 2. Radiotherapy procedures shall be planned and performed in such a way as to allow for outage of therapeutic apparatus causing deviation from accepted treatment standards. 3. The institution shall ensure that enough time is given for therapeutic session to be performed appropriately. 4. One therapeutic apparatus shall accommodate the maximum of five radical treatment patients within one hour. 5. Each irradiation fraction shall be preceded by patient identification, including the check-up of name, personal identification number (PESEL) or other identification numbers, date of birth, patient's photo, irradiation technique, irradiation parameters, irradiated area, tumor location, accessories used, etc. 6. At each stage of treatment, the institution shall show full respect for patients' privacy and personal data protection. 7. Patient's radiotherapy form shall be available at a given apparatus during each irradiation fraction. 8. First irradiation fraction in radical treatment patients and -in justified cases -in palliative treatment patients shall be attended by a radiation oncologist to verify patient's positioning and immobilisation, beam centring, correctness of radiation parameters and to provide patients with psychological support. 9. Medical physicist shall participate in radiation procedures at a radiation oncologist's or technologist's request. 10. Patients shall be positioned and immobilised by two radiologic technologists. V Ve er ri if fi ic ca at ti io on n o of f t tr re ea at tm me en nt t p pl la an n, , i ir rr ra ad di ia at ti io on n t ti im me e, , r ra ad di io ot th he er ra ap py y f fo or rm m T Tr re ea at tm me en nt t d de el li iv ve er ry y 11. Patients shall be positioned and immobilised as accurately, repetitively and comfortably as possible (in each machine used in the treatment process, according to instructions contained in treatment plan (as a text or diagram). 12. In the case of radical and palliative treatment, a radiation therapist shall participate in the first irradiation session performed according to a pre-set treatment plan. 13. During radiotherapy, patients shall be monitored by a radiologic technologist (audiovisual system). 14. Radiologic technologist shall confirm the consistency of physical parameters entered into the radiotherapy form with those actually delivered, in particular monitor units (exposure time).
1. During the first fraction, a radiation oncologist shall: a) instruct a radiologic technologist to take a portal image and verify patient's position in relation to the beam (whether the beam is well aimed at the target volume and whether OARs are outside the radiation field), according to a simulator or CT plan, b) verify patient's positioning and immobilisation, c) control the positioning (centring) of beams to ensure that all treatment parameters are consistent with the plan, d) check if all beam modifiers and accessories are suited for the patient being treated and properly positioned in relation to the patient and the therapeutic machine, e) instruct a radiologic technologist to perform in vivo dosimetry in order to check whether the dose administered is consistent with the planned one ±5% (according to ICRU Report 24). 2. Any changes in treatment plans shall be authenticated by a radiation oncologist and, where procedurally required, medical physicist. 3. The institution has established a code of practice in case of any changes in a treatment plan made during therapy. 4. During treatment, a radiation oncologist shall, at least once a week, perform a control and review of: a) entries in the radiotherapy form and medical documentation, b) patient's physical status (tolerance to therapy and radiation response), c) correctness of treatment delivery (in vivo dosimetry, portal imaging), d) deviation from a set radiological procedure shall each time be explained in medical documentation.
1. The institution has established a code of practice in case of therapy being interrupted or abandoned. 2. Treatment may be interrupted or abandoned by an attending or supervising physician, subject to prior consultation with a consultation committee, in cases of: a) wrong qualification for treatment, b) error in physical or technical radiation parameters found during treatment, c) patient's intolerance to treatment or threat to patient's life posed by continuing therapy. 3. The institution shall have immediate access to a defibrillator set in case of a threat to patient's life and health. 4. The institution has established a code of practice in case of acute conditions occurring during therapy.
1. The institution has defined the concepts of radiological incident and accident in accordance with national legal regulations (class A or B accidents). 2. The institution has put in place and documented a code of practice for incidents or accidents related to the use of ionizing radiation in radiotherapy and detailed rules for prevention of such accidents. 3. The institution shall document all radiation incidents or accidents and any corrective and protective measures taken in response to such events. 4. The institution has established rules for informing victims of radiological incidents and accidents of such events, their side effects and possible complications. 5. Patients who are victims of radiation incidents or accidents shall, if necessary, be subjected to appropriate examination or treatment.
1. Treatment quality control shall include the verification of: a) treatment physical parameters (dose, dose distribution, irradiation time), b) reproducibility of patient's positioning, c) method of patient's immobilisation (to ensure reproducibility), d) functional and mechanical stability, e) unambiguous patient identification, including documentation and individual accessories used in the process of treatment (masks, shields), f) correctness of treatment plan delivery (in vivo dosimetry, portal imaging), g) correctness of records made in the course of the treatment process (patient data), h) correctness of the recording and transfer of data and instructions between various stages, such as treatment planning (SPL), simulation, irradiation, and entries in medical documentation (medication log, radiotherapy form), i) patient's health status (tolerance to therapy, radiation response, therapy side effects).
V Ve er ri if fi ic ca at ti io on n o of f t tr re ea at tm me en nt t d de el li iv ve er ry y T Te er rm mi in na at ti io on n o or r w wi it th hd dr ra aw wa al l o of f t tr re ea at tm me en nt t M Me ed di ic ca al l r ra ad di ia at ti io on n a ac cc ci id de en nt ts s a an nd d i in nc ci id de en nt ts s T Tr re ea at tm me en nt tu ua al li it ty y c co on nt tr ro ol l 2. All stages of control shall be performed by independent professionals with no direct involvement in the activity controlled (e.g. treatment plans should be verified by a medical physicist not being a member of the planning team). 3. The institution shall periodically and systematically analyse results of in-vivo dosimetry and portal imaging.
The institution has established and documented radiation dose reference levels for X-ray examination in accordance with the national law (Annex 1 to the Regulation of 25 August 2005).
1. All activities, from patient's admission to discharge, including follow-up, shall be clearly defined, described and recorded in patient's medical documentation. 2. The institution has implemented and documented a procedure for supervising medical records, specifying, among other things, how they should be made (electronically, on paper, plates, films, etc.) and stored, as well as period and place of storage. 3. Period of storage shall comply with national requirements in this area. 4. The institution shall register: a) patient's medical history, b) identified risk factors, c) patient's general health status, d) results of physical examination, e) clinical stage of disease in line with adopted classification system (e.g. UICC) or staging method (e.g. FIGO), f) for patients treated previously, description of techniques used, direct outcome and evaluation of effects (e.g. leukopenia, impotence, nerve paralysis, etc.), g) diagnostic examination results, h) histopathology results. If treatment is delivered without histopathologic confirmation, the institution shall document rationale for treatment (e.g. certain lesions in the brain unattainable for biopsy), i) purpose of treatment (e.g. curative, adjuvant, palliative, alleviating pain), j) referral for treatment containing: -patient's name and date of birth, -aim and reasons for examination or treatment, -preliminary clinical diagnosis, -information necessary for proper performance of radiological procedure, k) patient's treatment plan (patient measurements, radiation parameters, anatomical description of the target volume (as defined by ICRU 38 or ICRU 50 and 62), l) treatment summary. 5. A radiotherapy form shall include: a) unambiguous patient identification and diagnosis, b) name of an attending doctor and, in his or her temporary absence, name of a substitute doctor, and a supervising doctor (should the attending doctor be not a radiation oncologist), c) readable, unambiguous and duly signed doctor's prescription to deliver radiation including:
• patient's medical exposure physical parameters and information enabling reproduction of patient's position on the treatment couch, • fractionated doses to the target volume for each radiation field (or total dose to all radiation fields), • time interval between successive fractions, • total dose and method used to record the cumulative dose, • for each radiation sensitive organ with dose histogram calculated, dose value shall be set, based on which, according to the therapeutic procedure used, the risk of late post-radiation damage is assessed; organs with no histogram calculated shall be assigned a maximum dose, • beam modifiers used (shields, filters, compensators) and their corresponding radiation fields, including methods of use. 6. At the end of treatment, patients shall receive discharge information including prescription for further conduct, care, diet, etc. 7. On patient's written request, the institution shall provide the patient with copies of his or her medical records. 8. Copies of discharge information are stored in patient's medical documentation. 9. All medical records and documents produced during treatment make it possible to reconstruct and track down complete datasets on patients, clinical information and treatment modalities. 10. Medical documentation (all records made -referral, medication log, treatment plan, etc.) shall be authenticated by a signature and stamp of persons responsible for entering particular data. 11. Medical documentation (radiotherapy form, treatment plan) shall be subject to periodical and systematic review at least: a) before the start of treatment, after one fraction at the latest, b) daily, by a radiologic technologist, c) weekly, by a radiation oncologist and medical physicist (radiation parameters), d) at each modification of a treatment plan or new radiation field, e) upon completion of treatment.
R Ra ad di ia at ti io on n d do os se e r re ef fe er re en nc ce e l le ev ve el ls s D Do oc cu um me en nt ta at ti io on n a an nd d r re ec co or rd ds s 12. Radiotherapy form shall be checked no less than once a week throughout the treatment period for correctness of doses administered to patients. The following shall be subject to detailed control: a) total doses absorbed by patients, b) compliance of radiotherapy form entries with treatment plan, including with regard to radiation regularity. 13. Data included in radiotherapy forms shall be controlled by authorised persons, their competences specified in the Quality Management System in Radiotherapy. 14. Controls shall be documented. 15 a) a procedure for treatment involving ionizing radiation specifying:
• methods for qualifying patients for treatment, • planning and simulation, • course of radiotherapy, • course of follow-up, • rules for replacing a therapeutic apparatus, in case of technical failure during radiotherapy, including conversion and check of treatment parameters, b) procedure for referring patients for treatment, c) procedure for priority admissions (decision to admit patients out of turn shall be taken on a collegial basis by two specialist physicians and recorded in patient registration documents), d) report checking dose by measurement of in vivo dosimetry, e) verification report of correct patient positioning in relation to the beam by a portal image. 21. All procedures, instructions and records shall be periodically and systematically reviewed (at least once a year) and updated if necessary. 22. Documentation updates are authorized, dated and numbered. 23. Archival copies shall be held exclusively by the Representative for QMS in Radiotherapy. 24 . The institution has put in place a detailed code of practice for persons who, on a free and voluntary basis, provide support and take care of patients subjected to medical exposure. 25. The institution has implemented and documented a code of practice in case of patient medical documentation being lost.
1. After completion of therapy, all patients shall be covered with regular follow-up performed by radiation oncologists. 2. The institution shall set the frequency of follow-up examinations for patients treated radically and palliatively, and if recommended for particular cases. 3. Follow-up should be systematic and consistent with the pre-set schedule. 4 . Results of follow-up examinations shall be recorded in patient's medical documentation. 5. Side effects (radiation response) shall be recorded using scoring systems for particular organs and tissues. 6. Treatment outcomes shall be regularly evaluated by physicians, radiotherapy team and internal clinical auditors.
1. The institution shall carry out, on a written request from the head of the institution, annual internal clinical audits. 2. Head of the institution shall appoint an auditing team to perform the internal clinical audit consisting of a radiation therapist, medical physicist and, if necessary, a medical engineer. 3. Internal and external clinical audits shall focus on patients and their treatment process from diagnosis, through decision to treat, referral for treatment, prescription, planning, therapy preparation and delivery, to follow-up. 
